We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Antibiotic-Resistant Gene Discovered in Salmonella

By LabMedica International staff writers
Posted on 05 Jun 2017
A team of investigators has discovered a gene, named fosA7, which confers a high level of resistance to the important broad-spectrum antibiotic fosfomycin. More...
The researchers found fosA7 in isolates of the pathogen Salmonella enterica from broiler chickens.

Fosfomycin has been a safe and effective agent for eliminating infections caused by multidrug-resistant bacteria. The product of fosA7 is the enzyme glutathione-S-transferase, which inactivates fosfomycin by binding to it and rupturing a molecular ring its structure. The “7” in fosA7 indicates that this is the seventh antibiotic resistant fosA gene that has been discovered.

“Vigilant monitoring for the spread of fosfomycin resistance in bacteria, isolated from humans and animals, is needed,” said corresponding author Moussa S. Diarra, PhD, research scientist at from Agriculture and Agri-Food Canada (AAFC; Guelph, Ontario, Canada). Currently, there is only limited fosfomycin resistance among Salmonella species. But the powerful resistance the fosA7 gene confers is worrisome, said Dr. Diarra. It could spread via horizontal gene transfer among different Salmonella serovar strains as well as other to bacterial pathogens, due to increased use of fosfomycin in both clinical and veterinary settings.

With that in mind, the researchers tested the strength of the resistance that fosA7 could confer on the closely related Salmonella enterica serovar Enteritidis by inserting the gene into the chromosome of non-antibiotic-resistant S. Enteriditis. Their worries were confirmed: the gene boosted the minimum concentration of fosfomycin required to inhibit microbe reproduction by more than 256-fold.

These results provided strong support for the hypothesis that fosA7 confers fosfomycin resistance, and that if fosA7 were transferred to plasmids it could induce a high level of resistance in recipient bacterial strains.

Fosfomycin resistance genes are often present in multidrug resistant bacteria. “This could further challenge the use of fosfomycin as an alternative treatment approach against urinary tract infections caused by both multidrug resistant E. coli, and blood infections from multidrug resistant Salmonella,” said Dr. Diarra.

The investigators have thus far found fosA7 only on S. enterica serovar Heidelberg and three other serovar strains. In the current study, they found fosA7 in all 15 Salmonella Heidelberg isolates in their collection. Salmonella enterica serovar Heidelberg is among the most common causes of human salmonellosis worldwide. The rise of resistance to multiple antibiotics, particularly to extended-spectrum cephalosporins, has limited the number of therapeutic options against this Salmonella serovar.

The study, by Rehman MA et al, was published May 22, 2017, in the journal Antimicrobial Agents and Chemotherapy.

Related Links
Agriculture and Agri-Food Canada


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.